IOBT

IO Biotech, Inc. filed an SEC 8-K form containing a notice of delisting or failure to satisfy a continued listing rule or standard (Item 3.01). This indicates potential issues with exchange listing requirements for the company.

AI-generated: summaries written by AI from the linked sources. How we use AI